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crobial activity against S. pneumoniae, S. pyogenes,M. catarrhalis and
H. inﬂuenzae, and remains a useful therapeutic drug for RTI.
http://dx.doi.org/10.1016/j.ijid.2012.05.619438 15th ICID Abstracts / International Journa
nﬂuenza A viruses isolated in Kenya in 2008-2009 despite lack of
idespread antiviral use.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.617
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Chulalongkorn University, Bangkok, Thailand
Mahidol University, Bangkok, Thailand
Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
Background: Although qnrA, encoding quinolone resistance
rotein, confers low-level resistance to ﬂuoroquinolone, its role in
uinolone resistance when associated with other resistant mecha-
isms remains unknown.
Methods: One hundred extended-spectrum beta-lactamase
ESBL) producing Escherichia coli were collected from Siriraj Hospi-
al (Bangkok, Thailand) and tested for qnrA by PCR. All qnrA positive
solates were investigated for gyrA mutations and a presence of
lass 1 integron by DNA sequencing and PCR. The locations of qnrA
nd intI1 genes were analyzed by Southern blot hybridization. Phe-
otypic characteristicswere studiedby antimicrobial susceptibility
est and time kill method.
Results: qnrA genes were found in 8% of ESBL-positive E. coli
8/100), conﬁrmed to be qnrA1 by DNA sequencing. All qnrA1 posi-
ive isolates also harbored intI1 gene. Double mutations (S83L and
87N) in gyrA were found in 50% (4/8) of qnrA1 positive isolates.
peciﬁc qnrA1 and intI1 probes showed both qnrA1 and intI1 genes
ould be found on the chromosome and/or plasmids. Some isolates
ossessed two integron elements. The MIC (ciproﬂoxacin) against
he isolate harboring both qnrA1 and gyrA with double mutations
as 2-fold higher than that against the isolate with only gyrA,
nd was much higher than that against the isolate harboring only
nrA1 (MICs of 64 g/ml, 32 g/ml, and 0.12 g/ml, respectively).
ccording to the time kill study, 0.5g/ml of ciproﬂoxacin showed
actericidal activity after six hours of incubation against the isolate
arboring only qnrA1. The bacteriostatic activity against the iso-
ate harboring only gyrA with double mutations could be observed
hen the concentrations of ciproﬂoxacin were ≤256 g/ml. The
egrowth of the isolate carried both genes in 64-128 g/ml at 24
ours of incubationwereobserved.Only 512g/ml of ciproﬂoxacin
howed bactericidal activity after four hours of incubation against
he isolate harboring both qnrA1 and gyrA with double mutations.
Conclusion: qnrA could integrate into the chromosome by class
integrons. Presence of ﬂuoroquinolone resistance elements on
oth plasmid and chromosome indicated high selection pressure
n E. coli and, may be, in other Gram-negative bacteria as well. The
nrAgeneconferredhigher-level ciproﬂoxacin resistanceondouble
utations in gyrA (S83L and D87N) background.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.618fectious Diseases 16S (2012) e317–e473
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Trends in antimicrobial susceptibility among bacterial isolates
from respiratory tract infections in Japanese hospitals partici-
pating in the Levoﬂoxacin Surveillance Group during the period
1994-2010
K. Yamaguchi ∗, A. Ohno, Y. Ishii, F. Kashitani, K. Tadeta
Toho University School of Medicine, Tokyo, Japan
Background: Fluoroquinolones (FQs) are among the most com-
monlyantimicrobialsused to treat respiratory tract infections (RTI).
FQ resistance is still very rare for Streptococcus pneumoniae, Strepto-
coccus pyogenes, Moraxella catarrhalis and Haemophilus inﬂuenzae.
However, FQ resistance in these organisms has been sporadically
reported over the past several years. We have already performed
nationwide surveillance on resistance for FQ and other antimicro-
bials in many bacterial clinical isolates in Japan since 1994. We
report herein surveillance data from 1994 to 2010 for the afore-
mentioned causative pathogens of RTI.
Methods: A total of 14,179 clinical isolates of the 4 species
were collected from 92 centers participating in the Levoﬂoxacin
SurveillanceGroup from1994 to2010 in Japan, andsusceptibility to
17 antibiotics was tested by broth microdilution methods accord-
ing to the Clinical Laboratory Standards Institute (CLSI) guidelines.
Quinolone resistance-determining region (QRDR) mutations in
gyrA, gyrB, parC, or parE were also identiﬁed by direct sequencing
method.
Results: 1. S. pneumoniae: The resistance rate for levoﬂoxacin
has ﬂuctuated at a low level of 1.06±0.71% (geometric mean±SD).
Interestingly, the peak value of MIC distribution in levoﬂoxacin-
susceptible isolates shifted from 0.5 g/mL to 1.0 g/mL from
2004 to 2007. QRDR-mutations were found in some of the LVFX-
susceptible isolates. The susceptibility to macrolides also declined
over time.
2. S. pyogenes: A high level of susceptibility to FQs,
cephalosporins, carbapenems was maintained, but the susceptibil-
ity to macrolides has rapidly decreased since 2002.
3. M. catarrhalis: M. catarrhalis maintained a susceptible rate
of almost 100% for FQs, the advanced-generation cephalosporins,
carbapenems and macrolides.
4. H. inﬂuenzae: Resistant isolates for levoﬂoxacin were not
found or were very few if any. The rate of -lactamase-negative
ampicillin-resistant has rapidly increased from 25.8% in 2002 to
57.9% in 2010.
Conclusion: Levoﬂoxacin stillmaintained ahigh level of antimi-
